Robert Hromas

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

NAR cancer

Cancer chemotherapy and pharmacology

The Journal of biological chemistry

Breast cancer research : BCR

University of Texas Health Science Center at San Antonio

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Health Science Center at San Antonio

United States

Dean, School of Medicine :: Medicine

Publications

Aruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, Yaxia Yuan, Daohong Zhou, Montaser Shaheen, Doraid T Sadideen, Austin Kirby, Elizabeth A Williamson, Yogesh K Gupta, Shaun K Olsen, Mingjiang Xu, Eva Loranc, Pramiti Mukhopadhyay, Alexander Pertsemlidis, Alexander J R Bishop, Patrick Sung, Jac A Nickoloff, Robert Hromas
TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. Nucleic acids research (2023)
Aruna S Jaiswal, Hyun-Suk Kim, Orlando D Schärer, Neelam Sharma, Elizabeth A Williamson, Gayathri Srinivasan, Linda Phillips, Kimi Kong, Shailee Arya, Anurag Misra, Arijit Dutta, Yogesh K Gupta, Christi A Walter, Sandeep Burma, Satya Narayan, Patrick Sung, Jac A Nickoloff, Robert Hromas
EEPD1 promotes repair of oxidatively-stressed replication forks. NAR cancer 5 (1) (2023)
Aruna S Jaiswal, Hyun-Suk Kim, Orlando D Schärer, Neelam Sharma, Elizabeth A Williamson, Gayathri Srinivasan, Linda Phillips, Kimi Kong, Shailee Arya, Anurag Misra, Arijit Dutta, Yogesh K Gupta, Christi A Walter, Sandeep Burma, Satya Narayan, Patrick Sung, Jac A Nickoloff, Robert Hromas
EEPD1 promotes repair of oxidatively-stressed replication forks. NAR cancer 5 (1) (2023)
Aruna S Jaiswal, Hyun-Suk Kim, Orlando D Schärer, Neelam Sharma, Elizabeth A Williamson, Gayathri Srinivasan, Linda Phillips, Kimi Kong, Shailee Arya, Anurag Misra, Arijit Dutta, Yogesh K Gupta, Christi A Walter, Sandeep Burma, Satya Narayan, Patrick Sung, Jac A Nickoloff, Robert Hromas
EEPD1 promotes repair of oxidatively-stressed replication forks. NAR cancer 5 (1) (2023)
Arunima Jaiswal, Aruna Jaiswal, Elizabeth A Williamson, Jonathon Gelfond, Guangrong Zheng, Daohong Zhou, Robert Hromas
Resistance to the BCL-XL degrader DT2216 in T-cell acute lymphoblastic leukemia is rare and correlates with decreased BCL-XL proteolysis. Cancer chemotherapy and pharmacology (2022)
Maegan L Capitano, Aruna Jaiswal, Hal E Broxmeyer, Yilianys Pride, Sarah Glover, Fatemah G Amlashi, Austin Kirby, Gayathri Srinivasan, Elizabeth A Williamson, Daniel Mais, Robert Hromas
A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease. PloS one 16 (7) (2021)
Fengshan Liang, Adam S Miller, Caroline Tang, David Maranon, Elizabeth A Williamson, Robert Hromas, Claudia Wiese, Weixing Zhao, Patrick Sung, Gary M Kupfer
The DNA-binding activity of USP1-associated factor 1 is required for efficient RAD51-mediated homologous DNA pairing and homology-directed DNA repair. The Journal of biological chemistry 295 (24) (2020)
Gayathri Srinivasan, Elizabeth A Williamson, Kimi Kong, Aruna S Jaiswal, Guangcun Huang, Hyun-Suk Kim, Orlando Schärer, Weixing Zhao, Sandeep Burma, Patrick Sung, Robert Hromas
MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers. Proceedings of the National Academy of Sciences of the United States of America 116 (35) (2019)
Robert Hromas, Hyun-Suk Kim, Gurjit Sidhu, Elizabeth Williamson, Aruna Jaiswal, Taylor A Totterdale, Jocelyn Nole, Suk-Hee Lee, Jac A Nickoloff, Kimi Y Kong
The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells. Breast cancer research : BCR 19 (1) (2017)
Maxim Norkin, Lakshmikanth Katragadda, Fei Zou, Sican Xiong, Myron Chang, Yunfeng Dai, Jack W Hsu, Jan S Moreb, Helen Leather, Hemant S Murthy, Nosha Farhadfar, Ying Li, Robert Hromas, Randy A Brown, Christopher R Cogle, John R Wingard
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia. Blood cancer journal 7 (12) (2017)
Gayathri Srinivasan, Gurjit Singh Sidhu, Elizabeth A Williamson, Aruna S Jaiswal, Nasreen Najmunnisa, Keith Wilcoxen, Dennie Jones, Thomas J George, Robert Hromas
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition. Cancer chemotherapy and pharmacology 80 (4) (2017)

Robert Hromas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Hromas